{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:29:38Z","timestamp":1790998178010,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIDA","award":["K23DA044342-01"],"award-info":[{"award-number":["K23DA044342-01"]}]},{"DOI":"10.13039\/100001862","name":"Christopher D. Smithers Foundation, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journalofsubstanceabusetreatment.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jsat.2018.06.001","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T12:02:45Z","timestamp":1527940965000},"page":"57-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Developing an opioid use disorder treatment cascade: A review of quality measures"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-6203","authenticated-orcid":false,"given":"Arthur Robin","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward V.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bisaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold A.","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee N.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Remien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsat.2018.06.001_bb0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/08897077.2015.1080784","article-title":"Admissions to detoxification after treatment: Does engagement make a difference?","volume":"37","author":"Acevedo","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2018.06.001_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.15288\/jsad.2015.76.57","article-title":"Performance measures and racial\/ethnic disparities in the treatment of substance use disorders","volume":"76","author":"Acevedo","year":"2015","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2018.06.001_bb0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15288\/jsad.2015.76.143","article-title":"Adoption of injectable naltrexone in US substance use disorder treatment programs","volume":"1","author":"Aletraris","year":"2015","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"10","key":"10.1016\/j.jsat.2018.06.001_bb0020","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/M14-0019","article-title":"A cascade of care for diabetes in the United States: Visualizing the gaps","volume":"161","author":"Ali","year":"2014","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1016\/j.jsat.2018.06.001_bb0025","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2018.06.001_bb0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1377\/hlthaff.2014.1330","article-title":"Despite resources from the ACA, most states do little to help addiction treatment programs implement care reform","volume":"34","author":"Andrews","year":"2015","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2018.06.001_bb0035","series-title":"The ASAM performance measures for the addiction specialist physician","author":"ASAM","year":"2014"},{"key":"10.1016\/j.jsat.2018.06.001_bb0040","series-title":"Health affairs blog","article-title":"Value-based payment as part of a broader strategy to address opioid addiction crisis","author":"Barrett","year":"2017"},{"key":"10.1016\/j.jsat.2018.06.001_bb0045","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsat.2016.12.012","article-title":"The Juvenile Justice Behavioral Health Services Cascade: A new framework for measuring unmet substance use treatment services needs among adolescent offenders","volume":"74","author":"Belenko","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jsat.2016.11.001","article-title":"Racial\/ethnic disparities in initiation of and engagement with addiction treatment among patients with alcohol use disorders in the veterans health administration","volume":"73","author":"Bensley","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.jsat.2018.06.001_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2013A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2018.06.001_bb0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsat.2017.01.019","article-title":"Quality of life as an outcome of opioid use disorder treatment: A systematic review","volume":"76","author":"Bray","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.jsat.2018.06.001_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.addbeh.2010.12.001","article-title":"Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders","volume":"36","author":"Brown","year":"2011","journal-title":"Addictive Behaviors"},{"issue":"8","key":"10.1016\/j.jsat.2018.06.001_bb0070","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1377\/hlthaff.2011.0480","article-title":"The looming expansion of public substance abuse treatment under the affordable care act","volume":"30","author":"Buck","year":"2011","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2018.06.001_bb0075","series-title":"Provisional counts of drug overdose deaths as of 8\/6\/2017","author":"Centers for Disease Control and Prevention. National Vital Statistics System","year":"2017"},{"key":"10.1016\/j.jsat.2018.06.001_bb0080","series-title":"Deploying the cascade of care framework to address the opioid epidemic means taking a closer look at quality measures","author":"Chalk","year":"2017"},{"key":"10.1016\/j.jsat.2018.06.001_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/add.13087","article-title":"Risk of mortality on and off methadone substitution treatment in primary care: A national cohort study","volume":"111","author":"Cousins","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.06.001_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2010","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.jsat.2018.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1001\/jama.1988.03410120089033","article-title":"The quality of care: How can it be assessed?","volume":"260","author":"Donabedian","year":"1988","journal-title":"JAMA"},{"issue":"313(16)","key":"10.1016\/j.jsat.2018.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department\u2013initiated buprenorphine\/naloxone treatment for opioid dependence: A randomized clinical trial","volume":"28","author":"D'Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2018.06.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s11414-013-9334-2","article-title":"Engagement in outpatient substance abuse treatment and employment outcomes","volume":"41","author":"Dunigan","year":"2014","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"8","key":"10.1016\/j.jsat.2018.06.001_bb0110","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2017.7818","article-title":"Medication-assisted treatment and opioid use before and after overdose in Pennsylvania Medicaid","volume":"318","author":"Frazier","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2018.06.001_bb0115","series-title":"Principles of addiction medicine","first-page":"497","article-title":"Linking addiction treatment with other medical and psychiatric treatment systems","author":"Friedmann","year":"2003"},{"issue":"6","key":"10.1016\/j.jsat.2018.06.001_bb0120","first-page":"793","article-title":"The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection","volume":"52","author":"Gardner","year":"2010","journal-title":"HIV\/AIDS; 2011"},{"issue":"3","key":"10.1016\/j.jsat.2018.06.001_bb0125","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsat.2013.10.005","article-title":"Criminal justice outcomes after engagement in outpatient substance abuse treatment","volume":"46","author":"Garnick","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2018.06.001_bb0130","first-page":"19","article-title":"Performance measures for alcohol and other drug services","volume":"29","author":"Garnick","year":"2006","journal-title":"Alcohol Research & Health"},{"issue":"4","key":"10.1016\/j.jsat.2018.06.001_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jsat.2007.03.002","article-title":"Are Washington circle performance measures associated with decreased criminal activity following treatment?","volume":"33","author":"Garnick","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0740-5472(02)00303-3","article-title":"Establishing the feasibility of performance measures for alcohol and other drugs","volume":"23","author":"Garnick","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2018.06.001_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jsat.2008.06.008","article-title":"Adapting Washington circle performance measures for public sector substance abuse treatment systems","volume":"36","author":"Garnick","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jsat.2010.11.008","article-title":"Lessons from five states: Public sector use of the Washington circle performance measures","volume":"40","author":"Garnick","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2018.06.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2012.01.011","article-title":"The Washington circle engagement performance measures' association with adolescent treatment outcomes","volume":"124","author":"Garnick","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.jsat.2018.06.001_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1353\/hpu.2014.0067","article-title":"Challenges and opportunities for integrating preventive substance-use-care services in primary care through the affordable care act","volume":"25","author":"Ghitza","year":"2014","journal-title":"Journal of Health Care for the Poor and Underserved"},{"issue":"39","key":"10.1016\/j.jsat.2018.06.001_bb0165","first-page":"1","article-title":"Quality measures at the interface of behavioral health and primary care","volume":"18","author":"Goldman","year":"2016","journal-title":"Current Psychiatry Reports"},{"issue":"3","key":"10.1016\/j.jsat.2018.06.001_bb0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1037\/1541-1559.5.3.228","article-title":"Predictors of initiation and engagement in VA substance use disorder (SUD) treatment","volume":"5","author":"Harris","year":"2008","journal-title":"Psychological Services"},{"issue":"(4)14","key":"10.1016\/j.jsat.2018.06.001_bb0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/pop.2008.0028","article-title":"HEDIS initiation and engagement quality measures of substance use disorder care: Impact of setting and health care specialty","volume":"12","author":"Harris","year":"2009","journal-title":"Population Health Management"},{"key":"10.1016\/j.jsat.2018.06.001_bb0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsat.2015.01.002","article-title":"Examining the specification validity of the HEDIS quality measures for substance use disorders","volume":"53","author":"Harris","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2018.06.001_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11414-008-9142-2","article-title":"Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes?","volume":"37","author":"Harris","year":"2008","journal-title":"The Journal of Behavioral Health Services & Research"},{"key":"10.1016\/j.jsat.2018.06.001_bb0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jsat.2006.12.015","article-title":"Veterans affairs facility performance on Washington circle indicators and casemix-adjusted effectiveness","volume":"33","author":"Harris","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-11-73","article-title":"Validation of the treatment identification strategy of HEDIS addiction quality measures: Concordance with medical record review","author":"Harris","year":"2011","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.jsat.2018.06.001_bb0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ADM.0000000000000203","article-title":"Specifying and pilot testing quality measures for the American Society of Addiction Medicine's Standards of Care","volume":"10","author":"Harris","year":"2016","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2018.06.001_bb0205","series-title":"Technical specifications for health plans","volume":"vol. 2","author":"HEDIS\u00ae","year":"2013"},{"key":"10.1016\/j.jsat.2018.06.001_bb0210","doi-asserted-by":"crossref","unstructured":"Hepner KA, Paddock SM, Watkins KE, et al. (2017). Association between quality measures and perceptions of care among patients with substance use disorders. Psychiatric Services; 68:1150\u20131156; doi: https:\/\/doi.org\/10.1176\/appi.ps.201600484.","DOI":"10.1176\/appi.ps.201600484"},{"key":"10.1016\/j.jsat.2018.06.001_bb0215","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ajad.12637","article-title":"Chronic pain and opioid abuse: Factors associated with health-related quality of life","volume":"26","author":"Jones","year":"2017","journal-title":"The American Journal on Addictions"},{"issue":"5","key":"10.1016\/j.jsat.2018.06.001_bb0220","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"0","key":"10.1016\/j.jsat.2018.06.001_bb0225","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2010.10.013","article-title":"Initiation and engagement in chronic disease management care for substance dependence","volume":"115","author":"Kim","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2018.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose, a cohort study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2018.06.001_bb0235","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"NEJM"},{"issue":"10118","key":"10.1016\/j.jsat.2018.06.001_bb0240","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicenter, open-label, randomize controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jsat.2018.06.001_bb0245","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jsat.2011.09.005","article-title":"Adolescent treatment initiation and engagement in an evidence-based practice initiative","volume":"42","author":"Lee","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0250","first-page":"1","article-title":"Evidence for misspecification of a nationally used quality measure for substance use treatment","author":"Mattke","year":"2017","journal-title":"Journal for Healthcare Quality"},{"issue":"11","key":"10.1016\/j.jsat.2018.06.001_bb0255","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1070-3241(00)26054-9","article-title":"Developing performance measures for alcohol and other drug services in managed care plans","volume":"26","author":"Mccorry","year":"2000","journal-title":"The Joint Commission Journal on Quality Improvement"},{"key":"10.1016\/j.jsat.2018.06.001_bb0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine\/naloxone utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0270","series-title":"Draft Report for Comment 2017","author":"National Quality Forum Behavioral Health","year":"2016"},{"key":"10.1016\/j.jsat.2018.06.001_bb0275","doi-asserted-by":"crossref","first-page":"588","DOI":"10.15288\/jsad.2017.78.588","article-title":"Association between process-based quality indicators and mortality for patients with substance use disorders","author":"Paddock","year":"2017","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"6","key":"10.1016\/j.jsat.2018.06.001_bb0280","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1377\/hlthaff.2016.0027","article-title":"Quality measures for mental health and substance use: Gaps, opportunities, and challenges","volume":"35","author":"Pincus","year":"2016","journal-title":"Health Affairs"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2018.06.001_bb0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugalcdep.2009.11.008","article-title":"Mortality among drug users after discharge from inpatient treatment: An 8-year prospective study","volume":"108","author":"Ravndal","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"14","key":"10.1016\/j.jsat.2018.06.001_bb0290","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004\u20132013 during the last decade, nonmedical use","volume":"314","author":"Saloner","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2018.06.001_bb0295","series-title":"Data on Substance Abuse Treatment Facilities. BHSIS Series S-88, HHS Publication No. (SMA) 17-5031","author":"SAMHSA Substance Abuse and Mental Health Services Administration","year":"2017"},{"issue":"13","key":"10.1016\/j.jsat.2018.06.001_bb0300","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/jama.2017.11525","article-title":"Measuring the cost of quality measurement a missing link in quality strategy","volume":"318","author":"Schuster","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2018.06.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1111\/add.13479","article-title":"Adopting the \u2018Cascade of Care\u2019 framework: An opportunity to close the implementation gap in addiction care?","author":"Socias","year":"2016","journal-title":"Addiction"},{"issue":"j1550","key":"10.1016\/j.jsat.2018.06.001_bb0310","first-page":"1","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2018.06.001_bb0315","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","article-title":"Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study","volume":"326","author":"Strang","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jsat.2018.06.001_bb0320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2010.08.005","article-title":"Advancing performance measures for use of medication in substance abuse treatment","volume":"40","author":"Thomas","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsat.2013.01.004","article-title":"Establishing the feasibility of measuring performance in use of addiction pharmacotherapy","volume":"45","author":"Thomas","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Mar 29","key":"10.1016\/j.jsat.2018.06.001_bb0330","article-title":"Applying American Society of Addiction Medicine performance measures in commercial health insurance and services data","author":"Thomas","year":"2018","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2018.06.001_bb0335","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2018.06.001_bb0340","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1521-0391.2011.00186.x","article-title":"Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","volume":"21","author":"Tkacz","year":"2011","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2018.06.001_bb0345","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajad.12174","article-title":"Trends in the use of buprenorphine by office-based physicians in the United States, 2003\u20132013","volume":"24","author":"Turner","year":"2015","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2018.06.001_bb0350","series-title":"Office of the Surgeon General, Facing Addiction in America: The surgeon general's report on alcohol, drugs, and health","first-page":"21","volume":"Chapter 4","author":"USDHHS, U.S. Department of Health and Human Services (HHS)","year":"2016"},{"issue":"22","key":"10.1016\/j.jsat.2018.06.001_bb0355","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies- tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.jsat.2018.06.001_bb0360","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jamainternmed.2017.3947","article-title":"Collaborative care for opioid and alcohol use disorders in primary care: The SUMMIT randomized clinical trial","volume":"177","author":"Watkins","year":"2017","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.jsat.2018.06.001_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.06.001","article-title":"Association between quality measures and mortality in individuals with co-occurring mental health and substance use disorders","volume":"69","author":"Watkins","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.06.001_bb0370","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.drugalcdep.2017.03.033","article-title":"Association between process measures and mortality in individuals with opioid use disorders","volume":"177","author":"Watkins","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2018.06.001_bb0375","series-title":"Health affairs blog","article-title":"To battle the opioid overdose epidemic, deploy the \u201cCascade of Care\u201d model","author":"Williams","year":"2017"},{"key":"10.1016\/j.jsat.2018.06.001_bb0380","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.jsat.2018.06.001_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101554","article-title":"The treatment cascade for chronic hepatitis C virus infection in the United States: A systematic review and meta-analysis","volume":"9","author":"Yehia","year":"2014","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1016\/j.jsat.2018.06.015","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000}}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218300394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547218300394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T05:20:06Z","timestamp":1534828806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547218300394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":76,"alternative-id":["S0740547218300394"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.06.001","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jsat.2018.06.015","asserted-by":"object"}]},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing an opioid use disorder treatment cascade: A review of quality measures","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}